Skip to content
Subscriber Only

China's Fosun Mulls Joint Bid for Bayer Animal Health Arm

  • Conglomerate considers teaming up with private equity firms
  • A bid could mark return to big-ticket deals for Chinese group
Fosun Chairman Guo Guangchang Presents Interim Results
Photographer: Paul Yeung/Bloomberg
Updated on

Fosun International Ltd. is considering a bid for Bayer AG’s animal-health business, people familiar with the matter said, a move that could mark a return to big-ticket deals for the Chinese conglomerate backed by billionaire Guo Guangchang.

Fosun has held talks with potential advisers and is considering teaming up with private equity firms or other financial investors for a joint offer, the people said. Bayer could start the sale process as soon as the next few weeks, the people said, asking not to be identified because the matter is private.